Alimera Sciences reports Q1 EPS (20c), consensus (25c)
moreView todays social media effects on ALIMView the latest stocks trending across Twitter. Click to view dashboardSee who Alimera is hiring next, click here to view […]
ALIM
ALIMERA SCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
moreView todays social media effects on ALIMView the latest stocks trending across Twitter. Click to view dashboardSee who Alimera is hiring next, click here to view […]
Alimera Sciences Reports First Quarter 2014 Financial Results
[PR Newswire] – ATLANTA, May 8, 2014 /PRNewswire/ — Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic … moreView todays social media effects on ALIMView the latest stocks trending across Twitter. Click to view dashboardSee who Alimera is hiring next, click here to view […]
Q1 2014 Alimera Sciences Inc Earnings Release – After Market Close
moreView todays social media effects on ALIMView the latest stocks trending across Twitter. Click to view dashboardSee who Alimera is hiring next, click here to view […]
7:00 am Alimera Sciences secures $35 mln debt facility
moreView todays social media effects on ALIMView the latest stocks trending across Twitter. Click to view dashboardSee who Alimera is hiring next, click here to view […]
Alimera Sciences To Present At Cowen And Company 34th Annual Healthcare Conference
[PR Newswire] – ATLANTA, Feb. 28, 2014 /PRNewswire/ — Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription … moreView todays social media effects on ALIMView the latest stocks trending across Twitter. Click to view dashboardSee who Alimera is hiring next, click here to view […]
Alimera Sciences Reports Fourth Quarter And Full Year 2013 Financial Results
[PR Newswire] – ATLANTA, Feb. 27, 2014 /PRNewswire/ — Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic … moreView todays social media effects on ALIMView the latest stocks trending across Twitter. Click to view dashboardSee who Alimera is hiring next, click here to view […]
Alimera Sciences To Release Fourth Quarter And Fiscal Year 2013 Financial Results
[PR Newswire] – ATLANTA, Feb. 20, 2014 /PRNewswire/ — Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription … moreView todays social media effects on ALIMView the latest stocks trending across Twitter. Click to view dashboardSee who Alimera is hiring next, click here to view […]
Alimera Sciences To Present At Citi 2014 Global Healthcare Conference
[PR Newswire] – ATLANTA, Feb. 13, 2014 /PRNewswire/ — Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription … moreView todays social media effects on ALIMView the latest stocks trending across Twitter. Click to view dashboardSee who Alimera is hiring next, click here to view […]
